Fig. 5From: Weight gain and comorbidities associated with oral second-generation antipsychotics: analysis of real-world data for patients with schizophrenia or bipolar I disorderIncreased Cardiometabolic Burden by CSWG in the 12 Months Post-Index in Patients With Cardiometabolic Conditions at Baseline. BD-I, bipolar I disorder; CSWG, clinically significant weight gain; SZ, schizophreniaBack to article page